Your browser doesn't support javascript.
loading
Nanoparticles for intravascular applications: physicochemical characterization and cytotoxicity testing.
Matuszak, Jasmin; Baumgartner, Jens; Zaloga, Jan; Juenet, Maya; da Silva, Acarília Eduardo; Franke, Danielle; Almer, Gunter; Texier, Isabelle; Faivre, Damien; Metselaar, Josbert M; Navarro, Fabrice P; Chauvierre, Cédric; Prassl, Ruth; Dézsi, László; Urbanics, Rudolf; Alexiou, Christoph; Mangge, Harald; Szebeni, János; Letourneur, Didier; Cicha, Iwona.
Afiliación
  • Matuszak J; Cardiovascular Nanomedicine Unit, Section of Experimental Oncology and Nanomedicine (SEON), ENT-Department, University Hospital Erlangen, Glückstr. 10a, 91054 Erlangen, Germany.
  • Baumgartner J; Department of Biomaterials, Max Planck Institute of Colloids & Interfaces, Science Park Golm, Potsdam, Germany.
  • Zaloga J; Cardiovascular Nanomedicine Unit, Section of Experimental Oncology and Nanomedicine (SEON), ENT-Department, University Hospital Erlangen, Glückstr. 10a, 91054 Erlangen, Germany.
  • Juenet M; Inserm U1148, LVTS, Paris Diderot University, Paris 13 University, Sorbonne Paris Cité, X. Bichat Hospital, Paris, France.
  • da Silva AE; Department of Targeted Therapeutics, MIRA Institute, University of Twente, Enschede, The Netherlands.
  • Franke D; nanoPET Pharma GmbH, Berlin, Germany.
  • Almer G; Clinical Institute of Medical & Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Texier I; CEA-LETI MINATEC/DTBS, Université Grenoble Alpes, Grenoble, France.
  • Faivre D; Department of Biomaterials, Max Planck Institute of Colloids & Interfaces, Science Park Golm, Potsdam, Germany.
  • Metselaar JM; Department of Targeted Therapeutics, MIRA Institute, University of Twente, Enschede, The Netherlands.
  • Navarro FP; Department of Experimental Molecular Imaging, University Clinic & Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany.
  • Chauvierre C; CEA-LETI MINATEC/DTBS, Université Grenoble Alpes, Grenoble, France.
  • Prassl R; Inserm U1148, LVTS, Paris Diderot University, Paris 13 University, Sorbonne Paris Cité, X. Bichat Hospital, Paris, France.
  • Dézsi L; Institute of Biophysics, Medical University of Graz, Graz, Austria.
  • Urbanics R; Nanomedicine Research & Education Center, Semmelweis University, Budapest, Hungary.
  • Alexiou C; SeroScience Ltd., Budapest, Hungary.
  • Mangge H; Cardiovascular Nanomedicine Unit, Section of Experimental Oncology and Nanomedicine (SEON), ENT-Department, University Hospital Erlangen, Glückstr. 10a, 91054 Erlangen, Germany.
  • Szebeni J; Clinical Institute of Medical & Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Letourneur D; Nanomedicine Research & Education Center, Semmelweis University, Budapest, Hungary.
  • Cicha I; SeroScience Ltd., Budapest, Hungary.
Nanomedicine (Lond) ; 11(6): 597-616, 2016 Mar.
Article en En | MEDLINE | ID: mdl-27003004
AIM: We report the physicochemical analysis of nanosystems intended for cardiovascular applications and their toxicological characterization in static and dynamic cell culture conditions. METHODS: Size, polydispersity and ζ-potential were determined in 10 nanoparticle systems including liposomes, lipid nanoparticles, polymeric and iron oxide nanoparticles. Nanoparticle effects on primary human endothelial cell viability were monitored using real-time cell analysis and live-cell microscopy in static conditions, and in a flow model of arterial bifurcations. RESULTS & CONCLUSIONS: The majority of tested nanosystems were well tolerated by endothelial cells up to the concentration of 100 µg/ml in static, and up to 400 µg/ml in dynamic conditions. Pilot experiments in a pig model showed that intravenous administration of liposomal nanoparticles did not evoke the hypersensitivity reaction. These findings are of importance for future clinical use of nanosystems intended for intravascular applications.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanopartículas Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Nanomedicine (Lond) Año: 2016 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanopartículas Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Nanomedicine (Lond) Año: 2016 Tipo del documento: Article País de afiliación: Alemania
...